Q2 EPS Estimate for United Therapeutics Lowered by Analyst
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Analysts at HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for shares of United Therapeutics in a research note issued on Monday, May 5th. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings per share of $7.02 for the […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Analysts at HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for shares of United Therapeutics in a research note issued on Monday, May 5th. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings per share of $7.02 for the […]
